These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17823780)

  • 1. Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence.
    Sommer WH; Rimondini R; Marquitz M; Lidström J; Siems WE; Bader M; Heilig M
    J Mol Med (Berl); 2007 Oct; 85(10):1089-97. PubMed ID: 17823780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central angiotensin II controls alcohol consumption via its AT1 receptor.
    Maul B; Krause W; Pankow K; Becker M; Gembardt F; Alenina N; Walther T; Bader M; Siems WE
    FASEB J; 2005 Sep; 19(11):1474-81. PubMed ID: 16126915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen.
    Campos LA; Couto AS; Iliescu R; Santos JA; Santos RA; Ganten D; Campagnole-Santos MJ; Bader M; Baltatu O
    Regul Pept; 2004 Jul; 119(3):177-82. PubMed ID: 15120478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous angiotensin and pressure modulate brain angiotensinogen and AT1A mRNA expression.
    Sangaleti CT; Crescenzi A; Michelini LC
    Hypertension; 2004 Feb; 43(2):317-23. PubMed ID: 14732738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats.
    Morishita R; Higaki J; Okunishi H; Kawamoto T; Ishii K; Nakamura F; Katahira K; Nagano M; Mikami H; Miyazaki M
    Clin Exp Pharmacol Physiol; 1991 Oct; 18(10):685-90. PubMed ID: 1764812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.
    Schinke M; Baltatu O; Böhm M; Peters J; Rascher W; Bricca G; Lippoldt A; Ganten D; Bader M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3975-80. PubMed ID: 10097148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress sensitivity is increased in transgenic rats with low brain angiotensinogen.
    Müller H; Kröger J; Jöhren O; Szymczak S; Bader M; Dominiak P; Raasch W
    J Endocrinol; 2010 Jan; 204(1):85-92. PubMed ID: 19808775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system and the developing retinal vasculature.
    Sarlos S; Wilkinson-Berka JL
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN).
    Monti J; Schinke M; Böhm M; Ganten D; Bader M; Bricca G
    Am J Physiol Regul Integr Comp Physiol; 2001 Jan; 280(1):R233-40. PubMed ID: 11124156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems.
    Kasper SO; Carter CS; Ferrario CM; Ganten D; Ferder LF; Sonntag WE; Gallagher PE; Diz DI
    Physiol Genomics; 2005 Nov; 23(3):311-7. PubMed ID: 16131528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct renin inhibition in a rat model of chronic allograft injury.
    Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M
    Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.
    Baltatu O; Silva JA; Ganten D; Bader M
    Hypertension; 2000 Jan; 35(1 Pt 2):409-12. PubMed ID: 10642333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain angiotensin: pathways and pharmacology.
    Unger T; Badoer E; Ganten D; Lang RE; Rettig R
    Circulation; 1988 Jun; 77(6 Pt 2):I40-54. PubMed ID: 2836110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ).
    Krskova K; Filipcik P; Zilka N; Olszanecki R; Korbut R; Gajdosechova L; Zorad S
    J Physiol Pharmacol; 2011 Aug; 62(4):403-10. PubMed ID: 22100841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
    Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
    Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.